Abstract
Procainamide (4-amino-N-[2-(diethylamino) ethyl] benzamide) is a sodium channel blocker, which acts as an effective antiarrhythmic agent used in the treatment of a variety of atrial and ventricular arrhythmias. The aim of this study was to prepare 99mTc-procainamide complex, apply different chromatographic techniques for the assay of radiolabeling yield and study its biodistribution as a novel radiopharmaceutical for heart imaging. 99mTc-procainamide was obtained with a maximum labeling yield of 95.76±0.20% via direct labeling method under optimum conditions of 200 μg of procainamide, 300 μL of buffer (carbonate) at pH 11, 30 μg SnCl2·2H2O at room temperature (25°C) for 15 min. In terms of in vitro stability, the complex was stable for 3 h. Chromatographic evaluation using paper chromatography, thin layer chromatography, gel chromatography, and high performance liquid chromatography showed reliable results for measuring the radiochemical yield. Biodistribution study of 99mTc-procainamide showed ratios of heart/lung and heart/liver (6.38±1.50, 2.06±0.31, respectively at 30 min post injection) which was comparable to that of 99mTc-sestamibi (7.4±2.00, 0.97±0.10, respectively at 60 min, P<0.05).
References
1. Hina, S., Roohi, S., Rajoka, M. I., Haque, A., Bokhari, T. H., Sohaib, M.: Preparation, quality control and biological characterization of 99mTc-vincristine. J. Radioanal. Nucl. Chem. 304, 553 (2015).10.1007/s10967-014-3836-0Search in Google Scholar
2. Banerjee, S., Pillai, M. R., Ramamoorthy, N.: Evolution of Tc-99m in diagnostic radiopharmaceuticals. Sem. Nucl. Med. 31(4), 260 (2001).10.1053/snuc.2001.26205Search in Google Scholar
3. Saha, G. B.: Fundamentals of Nuclear Pharmacy. Springer, New York (2010).10.1007/978-1-4419-5860-0Search in Google Scholar
4. Mikołajczak, R., Garnuszek, P.: Radiopharmaceuticals in cardiology. Nucl. Med. Rev. 15(1), 39 (2012).10.5603/NMR.2012.0008Search in Google Scholar
5. Baggish, A. L., Boucher, C. A.: Radiopharmaceutical agents for myocardial perfusion imaging. Circulation 118, 1668 (2008).10.1161/CIRCULATIONAHA.108.778860Search in Google Scholar
6. Gibbons, R. J.: Myocardial perfusion imaging. Heart 83, 355 (2000).10.1136/heart.83.3.355Search in Google Scholar
7. Sogbein, O. O., Pelletier-Galarneau, M., Schindler, T. H., Wei, L., Wells, R. G., Ruddy, T. D.: New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed. Res. Int. 2014, 942 (2014).10.1155/2014/942960Search in Google Scholar
8. Koch-Weser, J., Klein, S. W.: Procainamide dosage schedules, plasma concentrations, and clinical effects. J. Am. Med. Assoc. 215, 1454 (1971).10.1001/jama.1971.03180220036006Search in Google Scholar
9. Bigger, J. T., Heissenbuttel, R. H.: The use of procaineamide and lidocaine in the treatment of cardiac arrhythmias. Prog. Cardiovasc. Dis. 11, 515 (1969).10.1016/0033-0620(69)90004-8Search in Google Scholar
10. Koch-Weser, J.: Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease. Arch. Intern. Med. 129, 763 (1972).10.1001/archinte.1972.00320050087009Search in Google Scholar
11. Interian, A., Zaman, L., Velez-Robinson, E., Kozlovskis, P., Castel-lanos, A., Myerburg, R. J.: Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias. Am. Coll. Cardiol. 17, 1581 (1991).10.1016/0735-1097(91)90651-OSearch in Google Scholar
12. Brugada, R., Brugada, J., Antzelevitch, C., Kirsch, G. E., Potenza, D., Towbin, J. A., Brugada, P.: Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101(5), 510 (2000).10.1161/01.CIR.101.5.510Search in Google Scholar
13. Mian, M. S., El-Obeid, H. A., Al-Badr, A. A.: In: H. G. Brittain (Ed.), Analytical Profiles of Drug Substances and Excipients. Academic Press, California (2001).Search in Google Scholar
14. Jovanović, V., Maksin, T., Konstantinovska, D., Zmbova, B., Čvorić, J.: Radiochemical quality control of 99mTc-labelled radiopharmaceuticals. J. Radioanal Nucl. Chem. 59(1), 239 (1980).10.1007/BF02516852Search in Google Scholar
15. Yurt Kilcar, A., Biber Muftuler, F. Z.: Crucial role of radio-chromatography in clinical chemistry of nuclear medicine and radiopharmaceutical research. Austin Chromatogr. 1(2), 2 (2014).Search in Google Scholar
16. Arano, Y.: Recent advances in 99mTc radiopharmaceuticals. Ann. Nucl. Med. 16, 79 (2002).10.1007/BF02993710Search in Google Scholar
17. Zolle, I.: Technetium-99m Pharmaceuticals: Preparation and Quality Control in Nuclear Medicine. Springer, New York (2007).10.1007/978-3-540-33990-8Search in Google Scholar
18. Guo, H. X., Zhang, J. B., Ma, Z., Wang, Z. B.: Synthesis and biodistribution of 99mTcN-isopentyl xanthate as a potential myocardial perfusion imaging agent. J. Radioanal. Nucl. Chem. 275(1), 121 (2008).10.1007/s10967-007-6994-5Search in Google Scholar
19. Yang, Y., Zhang, J. X., Wang, J. J., Zhu, L.: Two novel procedures of preparation for [Tc (CO)2(NO)]2+labeled by EHIDA and its biodistribution. J. Radioanal. Nucl. Chem. 273(1), 31 (2007).10.1007/s10967-007-0706-zSearch in Google Scholar
20. Rhodes, B. A.: Considerations in the radiolabeling of albumin. Sem. Nucl. Med. 4, 281 (1974).10.1016/S0001-2998(74)80015-2Search in Google Scholar
21. Wyman, I. W., Macartney, D. H.: Host–guest complexations of local anaesthetics by cucurbit [7] uril in aqueous solution. Org. Biomol. Chem. 8(1), 247 (2010).10.1039/B915694ASearch in Google Scholar PubMed
22. Siddons, C. J.: Metal Ion Complexing Properies of Amide Donating Ligands (Doctoral dissertation, University of North Carolina at Wilmington) (2004).Search in Google Scholar
23. Iglesias, E.: Investigation of physico-chemical behaviour of local anaesthetics in aqueous SDS solutions. New J. Chem. 32(3), 517 (2008).10.1039/b716813fSearch in Google Scholar
24. Storey, A. E., Wadsworth, H. J., Powell, N. A., Duncanson, P.: N4 chelator conjugates. U.S. Patent No. 7,767,796. Washington, DC: U.S. Patent and Trademark Office (2010).Search in Google Scholar
25. Hansen, L., Lampeka, Y. D., Gavrish, S. P., Xu, X., Taylor, A. T., Marzilli, L. G.: Re (V) complexes with an open-chain quadridentate ligand containing two amine and two amido donors. Synthesis, characterization, and solution equilibria of Re2O3 (dioxo-tetH4) 2 and [ReO (H2O)(dioxo-tetH4)] Cl (dioxo-tetH6=1, 4, 8, 11-tetraazaundecane-5, 7-dione). Inorg. Chem. 39(25), 5859 (2000).10.1021/ic000173pSearch in Google Scholar
26. Chen, X., Guo, Y., Zhang, Q., Hao, G., Jia, H., Liu, B.: Preparation and biological evaluation of 99m Tc-CO-MIBI as myocardial perfusion imaging agent. J. Organomet. Chem. 693(10), 1822 (2008).10.1016/j.jorganchem.2008.02.006Search in Google Scholar
27. Hatada, K., Riou, L. M., Ruiz, M., Yamamichi, Y., Duatti, A., Lima, R. L., Goode, R. A., Watson, D. D., Beller, G. A., Glover, D. K.: 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. J. Nucl. Med. 45(12), 2095 (2004).Search in Google Scholar
28. Sanad, M. H., Borai, E. H., Fouzy, A. S. M.: Chromatographic separation and utilization of labeled 99m Tc-valsartan for cardiac imaging. J. Mol. Imag. Dynamic. 4(114), 2 (2014).10.4172/2155-9937.1000114Search in Google Scholar
29. Hao, G. Y., Zang, J. Y., Zhu, L., Guo, Y. Z., Liu, B. L.: Synthesis, separation and biodistribution of 99mTc-CO-MIBI complex. J. Labelled Comp. Radiopharm. 47(8), 513 (2004).10.1002/jlcr.839Search in Google Scholar
30. Crane, P. D., Onthank, D. C., Bourque, C. R., Heminway, S. J., Mazaika, T. J., Leav, I., Zambuto, G. F., Lazewatsky, J. L., Villamil-Perez, L., Carroll, T. R.: Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice. J. Nucl. Med. 36, 1862 (1995).Search in Google Scholar
31. Harden, R. M., Alexander, W. D., Kennedy, I.: Isotope uptake and scanning of stomach in man with 99mTc-pertechnetate. Lancet 289(7503), 1305 (1967).10.1016/S0140-6736(67)91597-8Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
